These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144 [TBL] [Abstract][Full Text] [Related]
4. Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain. Langford CF; Udvari Nagy S; Ghoniem GM Neurourol Urodyn; 2007; 26(1):59-62. PubMed ID: 17195176 [TBL] [Abstract][Full Text] [Related]
5. The occasional trigger point injection. Minty R; Kelly L; Minty A Can J Rural Med; 2007; 12(4):241-4. PubMed ID: 18076818 [No Abstract] [Full Text] [Related]
6. Electromyographically guided trigger point injections in the cervicothoracic musculature of obese patients: a new and unreported technique. Botwin KP; Patel BC Pain Physician; 2007 Nov; 10(6):753-6. PubMed ID: 17987097 [TBL] [Abstract][Full Text] [Related]
7. Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy. Hameroff SR; Crago BR; Blitt CD; Womble J; Kanel J Anesth Analg; 1981 Oct; 60(10):752-5. PubMed ID: 7027827 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Graboski CL; Gray DS; Burnham RS Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527 [TBL] [Abstract][Full Text] [Related]
13. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle. Tsai CT; Hsieh LF; Kuan TS; Kao MJ; Hong CZ Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708635 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with failure of trigger point injections. Hopwood MB; Abram SE Clin J Pain; 1994 Sep; 10(3):227-34. PubMed ID: 7833581 [TBL] [Abstract][Full Text] [Related]
15. The effects of myofascial trigger point injections are naloxone reversible. Fine PG; Milano R; Hare BD Pain; 1988 Jan; 32(1):15-20. PubMed ID: 3340420 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study. Ketenci A; Basat H; Esmaeilzadeh S Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000 [TBL] [Abstract][Full Text] [Related]
17. Myofascial pain syndrome in the differential diagnosis of chronic abdominal pain. Cimen A; Celik M; Erdine S Agri; 2004 Jul; 16(3):45-7. PubMed ID: 15382004 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H; Heinze A; Reichel G; Hefter H; Benecke R; Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of a myofascial trigger point injection for groin pain in patients with chronic prostatitis/chronic pelvic pain syndrome: a pilot study. Kim DS; Jeong TY; Kim YK; Chang WH; Yoon JG; Lee SC Arch Phys Med Rehabil; 2013 May; 94(5):930-6. PubMed ID: 23262156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]